Project

Control and Prevention of Tuberculosis (CAP-TB)

FHI 360’s Control and Prevention of Tuberculosis (CAP-TB) project aims to reduce the incidence and mortality of multidrug-resistant TB (MDR-TB) in Burma (Myanmar), China and Thailand. FHI 360 partners with the International Union Against Tuberculosis and Lung Disease, the World Health Organization, national tuberculosis programs, and local governmental and nongovernmental organizations in the Greater Mekong Subregion. The cornerstone of this project is to develop and implement a model for the programmatic management of MDR-TB. This model will strengthen the foundational components of efforts led by national tuberculosis programs. These components include early diagnosis (GeneXpert implementation), treatment initiation, community engagement for adherence, and prevention of multidrug-resistant TB through infection control interventions at the facility, community and household levels.

To learn more about the CAP-TB project, visit our online knowledge gateway at www.cap-tb.org. And to keep track of ongoing developments, follow us on our Facebook page.

Countries:
  • Asia Pacific Regional Office
  • China
  • Myanmar (Burma)
  • Thailand
Funder: USAID/Regional Development Mission for Asia (USAID/RDMA)
Duration: 2011 - 2017